HKSE - Delayed Quote • HKD
Global Bio-chem Technology Group Company Limited (0809.HK)
At close: 1:19 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
879,183.000
372,278.000
746,551.000
848,867.000
Cost of Revenue
894,539.000
337,681.000
698,200.000
774,767.000
Gross Profit
-15,356.000
34,597.000
48,351.000
74,100.000
Operating Expense
381,554.000
366,862.000
430,866.000
416,855.000
Operating Income
-396,910.000
-332,265.000
-382,515.000
-342,755.000
Net Non Operating Interest Income Expense
-714,887.000
-726,173.000
-790,314.000
-724,423.000
Pretax Income
-875,151.000
-1,573,784.000
-409,469.000
-2,410,926.000
Tax Provision
-89,705.000
-54,219.000
25,920.000
22,340.000
Net Income Common Stockholders
-721,032.000
-1,443,068.000
-400,801.000
-2,429,949.000
Diluted NI Available to Com Stockholders
-721,032.000
-1,443,068.000
-400,801.000
-2,429,949.000
Basic EPS
-0.08
-0.16
-0.04
-0.29
Diluted EPS
-0.08
-0.16
-0.04
-0.29
Basic Average Shares
8,907,405.717
8,907,405.717
8,907,405.717
8,507,940.377
Diluted Average Shares
8,907,405.717
8,907,405.717
8,907,405.717
8,507,940.377
Total Expenses
1,276,093.000
704,543.000
1,129,066.000
1,191,622.000
Net Income from Continuing & Discontinued Operation
-721,032.000
-1,443,068.000
-400,801.000
-2,429,949.000
Normalized Income
-1,253,203.255
-1,444,839.782
-1,425,016.750
-1,889,073.000
Interest Income
172.000
45.000
271.000
403.000
Interest Expense
715,059.000
726,218.000
790,585.000
724,826.000
Net Interest Income
-714,887.000
-726,173.000
-790,314.000
-724,423.000
EBIT
-160,092.000
-847,566.000
381,116.000
-1,686,100.000
EBITDA
161,907.000
-517,057.000
783,629.000
-1,229,172.000
Reconciled Cost of Revenue
894,539.000
337,681.000
698,200.000
774,767.000
Reconciled Depreciation
321,999.000
330,509.000
402,513.000
456,928.000
Net Income from Continuing Operation Net Minority Interest
-721,032.000
-1,443,068.000
-400,801.000
-2,429,949.000
Total Unusual Items Excluding Goodwill
592,950.000
1,835.000
1,365,621.000
-721,168.000
Total Unusual Items
592,950.000
1,835.000
1,365,621.000
-721,168.000
Normalized EBITDA
-431,043.000
-518,892.000
-581,992.000
-508,004.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
60,778.745
63.218
341,405.250
-180,292.000
12/31/2020 - 3/16/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade